1. Home
  2. QNCX vs ALOT Comparison

QNCX vs ALOT Comparison

Compare QNCX & ALOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • ALOT
  • Stock Information
  • Founded
  • QNCX 2012
  • ALOT 1969
  • Country
  • QNCX United States
  • ALOT United States
  • Employees
  • QNCX N/A
  • ALOT N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • ALOT Computer peripheral equipment
  • Sector
  • QNCX Health Care
  • ALOT Technology
  • Exchange
  • QNCX Nasdaq
  • ALOT Nasdaq
  • Market Cap
  • QNCX 90.8M
  • ALOT 86.7M
  • IPO Year
  • QNCX 2019
  • ALOT N/A
  • Fundamental
  • Price
  • QNCX $1.60
  • ALOT $10.02
  • Analyst Decision
  • QNCX Strong Buy
  • ALOT
  • Analyst Count
  • QNCX 6
  • ALOT 0
  • Target Price
  • QNCX $8.00
  • ALOT N/A
  • AVG Volume (30 Days)
  • QNCX 124.9K
  • ALOT 15.2K
  • Earning Date
  • QNCX 11-12-2025
  • ALOT 09-09-2025
  • Dividend Yield
  • QNCX N/A
  • ALOT N/A
  • EPS Growth
  • QNCX N/A
  • ALOT N/A
  • EPS
  • QNCX N/A
  • ALOT N/A
  • Revenue
  • QNCX N/A
  • ALOT $151,593,000.00
  • Revenue This Year
  • QNCX N/A
  • ALOT N/A
  • Revenue Next Year
  • QNCX N/A
  • ALOT N/A
  • P/E Ratio
  • QNCX N/A
  • ALOT N/A
  • Revenue Growth
  • QNCX N/A
  • ALOT 0.63
  • 52 Week Low
  • QNCX $0.69
  • ALOT $7.53
  • 52 Week High
  • QNCX $2.45
  • ALOT $17.24
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 47.89
  • ALOT 37.36
  • Support Level
  • QNCX $1.56
  • ALOT $9.79
  • Resistance Level
  • QNCX $1.65
  • ALOT $11.99
  • Average True Range (ATR)
  • QNCX 0.08
  • ALOT 0.62
  • MACD
  • QNCX 0.00
  • ALOT -0.15
  • Stochastic Oscillator
  • QNCX 64.65
  • ALOT 10.45

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

Share on Social Networks: